These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7292724)

  • 1. [Prevalence of the individual stages of prostatic cancer at the time of diagnosis].
    Mogensen P; Frimodt-Møller C
    Ugeskr Laeger; 1981 Jun; 143(26):1644-6. PubMed ID: 7292724
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of prostatic cancer (Drug Administration, Sweden)].
    Lakartidningen; 1993 May; 90(18):1766, 1769-73. PubMed ID: 8492635
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: a retrospective study.
    Cindolo L; Benincasa G; Autorino R; Domizio S; De Rosa G; Testa G; D'Armiento M; Altieri V
    Oncol Rep; 2001; 8(2):269-71. PubMed ID: 11182038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and staging of locally confined prostatic cancer.
    Peeling WB; Griffiths GJ; Clements R
    Prog Clin Biol Res; 1990; 359():181-9; discussion 223-9. PubMed ID: 2284290
    [No Abstract]   [Full Text] [Related]  

  • 5. Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer.
    Taylor SH; Merriman KW; Spiess PE; Pisters L
    Cancer; 2006 Feb; 106(3):559-65. PubMed ID: 16369982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostatic cancer developing after transurethral resection of the prostate for benign prostatic hyperplasia].
    Tanaka Y; Aoyama H; Momose H; Ono T; Samma S; Tanaka N; Akiyama T; Tani Y; Masuda Y; Matsuki H; Tani M; Tanaka M
    Hinyokika Kiyo; 2001 Jan; 47(1):11-4. PubMed ID: 11235214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognosis in stage a prostate cancer].
    Murase T; Kuriyama M; Maeda S; Ando Y; Itoh H; Watanabe H
    Hinyokika Kiyo; 1996 Sep; 42(9):639-43. PubMed ID: 8918661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early prostate cancer diagnosis and therapy.
    Glodé LM
    Adv Intern Med; 2000; 45():41-64. PubMed ID: 10635045
    [No Abstract]   [Full Text] [Related]  

  • 10. [Small cell prostatic carcinoma. Presentation of diagnosis, therapy and prognosis based on a case report].
    Munker R; Schalhorn A
    Fortschr Med; 1994 Nov; 112(33):473-5. PubMed ID: 7843670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early stages of prostate cancer].
    Cherkasskiĭ LA; Maksimova NA; Golaĭko VIu
    Vopr Onkol; 1997; 43(3):347-9. PubMed ID: 9245098
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cycloplatam in the treatment of patients with disseminated prostatic cancer].
    Matveev BP; Gorbunova VA; Smirnova NB; Zhumagazin ZhD; Bukharkin BV; Orel NF
    Urol Nefrol (Mosk); 1996; (3):34-6. PubMed ID: 8928330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histopathological diagnosis of prostatic cancer].
    Wasilewski A; Szymanowski J
    Pol Tyg Lek; 1981 Jun; 36(25):909-11. PubMed ID: 7301641
    [No Abstract]   [Full Text] [Related]  

  • 14. Wait and see: experience with B1 lesions.
    Whitmore WF; Rosenberg S; Chopp R
    Prog Clin Biol Res; 1987; 243B():387-94. PubMed ID: 3659033
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate specific antigen in the diagnosis and staging of prostate cancer.
    Jung P; Wolff JM; Mattelaer P; Jakse G
    Acta Urol Belg; 1996 Sep; 64(3):1-6. PubMed ID: 8946774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostatic cancer between 50 and 60. A more than 20-year-long retrospective study. Apropos of 65 case reports].
    Aubert J; Orget J; Bon D; Marroncle M
    Acta Urol Belg; 1993 Dec; 61(4):5-12. PubMed ID: 7507634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of phased-array 3.0-T and endorectal 1.5-T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer.
    Park BK; Kim B; Kim CK; Lee HM; Kwon GY
    J Comput Assist Tomogr; 2007; 31(4):534-8. PubMed ID: 17882027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
    Aus G
    Eur Urol; 2009 Jun; 55(6):1331. PubMed ID: 19286303
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
    Albertson PC
    Eur Urol; 2009 Jun; 55(6):1331-2. PubMed ID: 19286304
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and staging of prostatic carcinoma.
    Mohler JL
    J S C Med Assoc; 1994 May; 90(5):214-6. PubMed ID: 8028291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.